Drug Trial Radar · NCT06060977
A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of IMG-007 in Adult Alopecia Areata Participants
Last checked: Nov 19, 2026Latest source record: Feb 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
29
Actual
Start
Sep 25, 2023
Primary completion
Jan 14, 2025
Study completion Jan 14, 2025
Sponsor
- Lead sponsor
- Inmagene LLCIndustry
- Sponsor type
- Industry
- First posted
- Sep 29, 2023
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Non randomized
- Model
- Sequential
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective of the study is to evaluate the safety of IMG-007 in adults with Alopecia Areata.
Conditions
- Alopecia Areata (AA)
Interventions
IMG-007Drug
Intravenous Infusion
Primary outcomes
What the sponsor says the trial is designed to measure.
- Evaluation of Adverse Events in ParticipantsTime frame: Adverse events were collected from baseline through the end of the study, a period of up to 24 weeks.
Locations
17 sites in 2 countries. Site status is shown where the registry gives one.
Northwest Arkansas Clinical Trials Center, PLLC/ Hull Dermatology P.A.
Rogers, Arkansas
Torrance Clinical Research Institute Inc.
Lomita, California
Alliance Clinical Research of Tampa
Tampa, Florida
Dawes Fretzin Clinical Resarch Group, LLC
Indianapolis, Indiana
Options Research Group
West Lafayette, Indiana
Lahey Hospital & Medical Center
Burlington, Massachusetts
Great Lakes Research Group Inc.
Bay City, Michigan
Skin Cancer and Dermatology Institute
Reno, Nevada
Skin Search of Rochester, Inc.
Rochester, New York
Stride Clinical Research LLC
Sugar Land, Texas
Dermatology Specialists of Spokane
Spokane, Washington
Innovaderm Research Inc.
Montreal, Canada
SimcoMed Health Ltd.
Barrie, Ontario, Canada
Skin Health
Cobourg, Ontario, Canada
Guelph Dermatology Research
Guelph, Ontario, Canada
Research Toronto
Toronto, Ontario, Canada
Centre de Recherche Saint-Louis
Québec, Quebec, Canada
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.